Enterprise Overview: Hebei Hejia Pharmaceutical Technology Group Co., Ltd.
Hebei Hejia Pharmaceutical Technology Group Co., Ltd. is a leading force in innovative pharmaceutical manufacturing, offering a diverse portfolio of high-purity antibiotic intermediates and finished pharmaceutical products. Established in Shijiazhuang Economic and Technological Development Area, the company emphasizes expertise, authoritativeness, and trustworthiness in every facet, from R&D to precision production and global supply.
- Official Website: hejiachemicaltech.com
- Address: 80 Hainan Road, Shijiazhuang Economic and Technological Development Area
Introduction: The Significance of Ceftezole Sodium (CAS No.: 72558-82-8) in Modern Pharmaceuticals
As global healthcare evolves, the demand for ceftezole sodium (CAS No.: 72558-82-8) continues to ascend. This broad-spectrum, beta-lactam antibiotic is renowned for its outstanding efficacy against Gram-positive and select Gram-negative bacteria, translating into robust medical solutions for healthcare facilities and pharmaceutical manufacturers. The sodium salt form ensures remarkable water solubility and stability, which are pivotal for sterile injectable formulations.
This comprehensive review explores:
- Industry trends and market evolution related to ceftezole sodium
- Its major technical parameters and application in various medical scenarios
- Authoritative references to ensure EEAT excellence for B2B and regulatory buyers
- Tabular and visualized data on specifications, performance, and competitive benchmarking
- Critical FAQ for industry specialists
Product Profile: Ceftezole Sodium (CAS No.: 72558-82-8) Key Features
| Product Name | ceftezole sodium |
|---|---|
| Chemical Abstracts No. | 72558-82-8 |
| Molecular Formula | C19H16N5NaO5S2 |
| Molecular Weight | 497.48 g/mol |
| Appearance | White or almost white crystalline powder |
| Solubility | Freely soluble in water |
| Stability | Stable under recommended storage (cool, dry place) |
| Purity (HPLC) | ≥98.0% |
| Application | Antibacterial – injectable formulations for respiratory, urinary, soft tissue, postoperative infections |
| Pharmacopoeial Standard | Conforms to EP/USP/ChP |
Contact Hebei Hejia Pharmaceutical Technology Group
- Phone: +86-311-89928201
- Mobile: +86 311 89928216
- Email: fairy_liu@hejia-china.com
- Address: 80 Hainan Road, Shijiazhuang Economic and Technological Development Area
Industry Trends and Market Dynamics for Ceftezole Sodium
The global demand for ceftezole sodium is driven by escalating occurrences of infectious diseases, increasing awareness regarding antibiotic stewardship, and stringent regulations for injectable antibiotic quality. According to the Drug Information Association and the International Society of Chemotherapy, cephalosporins represent a significant therapeutic class, with ceftezole sodium showing heightened relevance in the Asian and European pharmaceutical sectors.
Emerging market growth is projected at 5.8% CAGR through 2030, with increasing applications in hospital-acquired infection control and specialized surgical prophylaxis programs.
(Drugs & Therapy Perspectives)
Technical Parameters & Specifications of Ceftezole Sodium
Ceftezole Sodium Key Technical Parameters Table
| Parameter | Value | Standard/Reference |
|---|---|---|
| Chemical Name | Ceftezole Sodium | USP/EP/ChP |
| CAS Number | 72558-82-8 | CAS Registry |
| Molecular Formula | C19H16N5NaO5S2 | Pharmacopoeial |
| Molecular Weight | 497.48 g/mol | Calculated |
| Purity (HPLC) | ≥98.0% | Pharmacopoeia |
| Activity Spectrum | Broad (G+ & selective G-) | MIC Tests |
| Solubility | Freely soluble in water | USP/EP |
| Storage Condition | Cool, dry ( | Manufacturer Specs |
| Shelf Life | 3 Years | Batch Analysis |
Ceftezole Sodium Technical Index & Trend Visualization
Application Scenarios & Clinical Relevance of ceftezole sodium
Pharmaceutical-grade ceftezole sodium is integral to the formulation of injectable antibiotics intended for hospital and specialty clinic use. Its therapeutic profile encompasses:
- Respiratory tract infections (RTIs): Effective against Streptococcus pneumoniae and Staphylococcus aureus.
- Urinary tract infections (UTIs): Rapidly clears common uropathogens including Escherichia coli.
- Skin and soft tissue infections (SSTIs): Used perioperatively and for wound management.
- Post-operative infection prevention: Especially in orthopedic and abdominal surgeries.
- Research applications: Referenced in pharmaceutical analysis literature.
Why Trust Hebei Hejia for ceftezole sodium Supply?
- Strictest Standards: Every batch is validated to meet or exceed USP/EP/ChP requirements for purity, water content, and residual solvents.
- Compliant Manufacturing: Produced in GMP and ISO-certified production environments.
- Traceability & Documentation: Full COA, MSDS, and batch traceability supplied.
- Industry Recognition: Products referenced by leading pharmacopoeia and cited in peer-reviewed journals.
- Global Reach: Responsive logistic solutions ensure on-spec, on-time delivery worldwide.
EEAT Optimization: Citing Authority in Ceftezole Sodium
Ceftezole sodium stands out for industry professionals due to its extensive documentation, including peer-reviewed research, official pharmacopoeial monographs, and regulatory guidelines. Expertise from the Elsevier Pharmaceutical Analytics Series and clinical studies indexed by PubMed consistently underscore its pharmacological value and safety.
Key forums for discussion and up-to-date market intelligence include PharmaCompass, Chemsynthesis, and in-depth industry webinars presented by Drug Information Association (DIA).
Professional FAQ: Insights for Industry Stakeholders
Frequently Asked Technical Questions
A1: The structure contains a beta-lactam core typical of cephalosporins, with a unique tetrazole moiety that imparts a broad antibacterial spectrum and resistance to certain beta-lactamases. Its sodium salt form ensures superior solubility and suitability for injectable medications.
A2: Industry standards require ≥98% purity by HPLC, water content <1.0%, and total impurities under 1.2%. When stored properly, stability exceeds 36 months, retaining >95% activity at room temperature.
A3: Reference standards include United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Chinese Pharmacopoeia (ChP), which define criteria for purity, water content, residue on ignition, heavy metals, and microbial limits.
A4: It is primarily formulated into sterile injectables—vials or ampoules—using excipients that preserve stability, with final product testing for endotoxins and sterility. Compatibility with other cephalosporins is typically high.
A5: Store in tightly sealed, moisture-proof container111s at
A6: As with all injectable antibiotics, use proper PPE when handling. Avoid dust inhalation and prolonged exposure. Refer to MSDS for detailed toxicity, first aid, and environmental release protocols.
A7: Yes. Hebei Hejia offers custom batch sizes, altered impurity profiles, specific water content requirements, and specialist documentation to meet varied client regulatory and research needs.
Conclusion: The Strategic Value of ceftezole sodium (CAS No.: 72558-82-8) for Pharmaceutical Innovation
With its remarkable technical profile, regulatory pedigree, and responsive global supply chain, ceftezole sodium (CAS No.: 72558-82-8) stands as an irreplaceable backbone compound for modern antibiotic development and manufacture. Companies partnering with Hebei Hejia Pharmaceutical Technology Group Co., Ltd. gain a strategic supplier who ensures validated quality, robust technical support, and uninterrupted delivery of this critical API.
For deeper technical insights and authoritative references regarding ceftezole sodium, consult the following industry resources and journals:
- ScienceDirect: Analytical Techniques for Ceftazidime and Other Cephalosporins
- PharmacyForum.org – Ceftetrizole: Clinical and Technical Perspectives
- PubMed: Clinical Evaluation of Ceftezole Sodium
- PharmaCompass: Ceftizole Sodium Global Marketplace
- Wiley: Cephalosporins - Chemistry and Microbiology
